ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Flexible Integrations To Reduce Risks And Increase Efficiencies

  Learn how a trial team kept the blind of central lab samples and patient treatment across a Phase III and extension trial, whilst optimizing the supply chain.

• End-To-End Inventory Control Supports Biotech's Expanding Portfolio

  Many organizations struggle with siloed operations, but this modern GxP inventory solution solves these challenges by providing a centralized, cloud-based platform for end-to-end visibility.

• How A Biotech Startup Transformed Its Clinical Trial Supply Management

  Don’t let your trial get lost in the shuffle of legacy vendors. See how a high-touch, consultative approach can protect your study’s future.

• 5 Ways To Get Ready For IRT Regulatory Inspections

  Preparing for a regulatory inspection during a clinical trial can be daunting. Learn about the importance of clear roles, audit trails, data integrity, and training, and get recommendations to help.

• Effective Use Of IRT In Decentralized And Hybrid Clinical Trials

  Uncover the ways interactive response technologies are helping trial sponsors manage the distribution of medications, forecast trial supply, and integrate workflows with other technology platforms.

• From Bench To Breakthrough: How Custom Kitting Fuels Precision Trials

  Reduce trial variability and ensure protocol compliance with standardized custom kitting that transforms complex sample collection into a streamlined, strategic advantage for clinical success.

• RTSM: Randomization And Cohort Management, IP Inventory Management

  Signant’s SmartSignals® RTSM solution helped an innovative biopharmaceutical company secure an FDA Orphan Drug designation for its cardiomyopathy drug.

• GxP Inventory Solution Delivers Real-Time Visibility, Operational Efficiency

  Explore how unified forecasting and GxP-level inventory control can streamline your clinical supply chain, reduce risk, and strengthen oversight across every trial you run.

• Benefits Of Electronic Labels: Investigational Medicinal Products

  When a new therapeutic drug, medical device, vaccine, or other investigational medicinal product (IMP) is developed, learn why a label must be on its packaging that provides relevant and important information.

• Rethinking RTSM Software: When Bigger Isn't Better

  Don’t let legacy vendor inertia jeopardize your trial. Discover why agility and deep RTSM expertise are the new benchmarks for reducing risk and ensuring precision in clinical operations.